Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair

See also
Status	Clinical Trial	Phase
Completed	`NCT01183325` - Prospective Evaluation of the Proceed Ventral Patch With and Without Laparoscopic Evaluation	N/A
Completed	`NCT01673568` - Abdominal Binder to Reduce Pain and Seroma Formation	N/A
Completed	`NCT01962480` - The Effect of Laparoscopically Closing the Hernia Defect in Laparoscopic Ventral Hernia Repair on Postoperative Pain	N/A
Withdrawn	`NCT02730936` - Antimicrobial Hernia Repair Device	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT01183325 - Prospective Evaluation of the Proceed Ventral Patch With and Without Laparoscopic Evaluation

N/A

Completed

NCT01673568 - Abdominal Binder to Reduce Pain and Seroma Formation

N/A

Completed

NCT01962480 - The Effect of Laparoscopically Closing the Hernia Defect in Laparoscopic Ventral Hernia Repair on Postoperative Pain

N/A

Withdrawn

NCT02730936 - Antimicrobial Hernia Repair Device

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT01784822
Study type	Observational
Source	Cook
Contact
Status	Completed
Phase	N/A
Start date	February 2013
Completion date	June 2016

Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms